Neuroprotective effects of copper/zinc-dependent superoxide dismutase against a wide variety of death-inducing stimuli and proapoptotic effect of familial amyotrophic lateral sclerosis mutations

Molecular Brain Research

Volumn 109, Issue 1-2, 2002, Pages 189-197

  Patel, Yogesh ^a   Moraes, Yolanda Collaco ^a,b   Latchman, David ^a   Coffin, Robert ^c   De Belleroche, Jacqueline ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b CHARING CROSS HOSPITAL   (United Kingdom)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Cell survival apoptosis; Copper zinc superoxide dismutase (SOD1); HSV viral gene delivery; Neuroprotection; SOD1 mutations G93A and G93R

Indexed keywords

COPPER; GAMMA INTERFERON; STAUROSPORINE; SUPEROXIDE DISMUTASE; ZINC;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL LINE; CELL SURVIVAL; CONTROLLED STUDY; FAMILIAL DISEASE; GENE TARGETING; GENETIC TRANSFECTION; HYPOXIA; IN VIVO STUDY; MUTATION; NERVE CELL; NEUROPROTECTION; NICK END LABELING; NONHUMAN; ONSET AGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION; VIRUS; WILD TYPE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; APOPTOSIS; CELL LINE; CELL SURVIVAL; CULTURE MEDIA, SERUM-FREE; ENZYME INHIBITORS; GENETIC VECTORS; HUMANS; IN SITU NICK-END LABELING; INTERFERON TYPE II; MUTAGENESIS, SITE-DIRECTED; NEURONS; NEUROPROTECTIVE AGENTS; STAUROSPORINE; SUPEROXIDE DISMUTASE;

EID: 0037203301     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(02)00560-0     Document Type: Article

References (37)

1. Beckman J.S., Estevez A.G., Crow J.P., Barbeito L. Superoxide dismutase and the death of motoneurons in ALS. Trends Neurol. Sci. 24:2001;S15-20.
2. Bergeron C., Petrunka C., Weyer L. Copper/zinc superoxide dismutase expression in the human central nervous system. Correlation with selective neuronal vulnerability. Am. J. Pathol. 148:1996;273-279.
3. Coffin R.S., MacLean A.R., Latchman D.S., Brown S.M. Gene delivery to the central and peripheral nervous systems of mice using HSV1 ICP34.5 deletion mutant vectors. Gene Ther. 3:1996;886-891.
4. Coffin R.S., Howard M.K., Cumming D.V.E., Collery C.M., McEwan J., Yellon D.M., Marber M.S., MacLean S.R., Brown S.M., Latchman D.S. Gene delivery to the heart in vivo and to cardiac myocytes and vascular smooth muscle cells in vitro using herpes virus vectors. Gene Ther. 3:1996;560-566.
5. Cleveland D.W., Rothstein J.D. From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat. Rev. Neurosci. 2:2001;806-819.
6. Crow J.P., Sampson J.B., Zhuang Y., Thompson J.A., Beckman J.S. Decreased zinc affinity of amyotrophic lateral sclerosis-associated mutants leads to enhanced catalysis of tyrosine nitration by peroxynitrite. J. Neurochem. 69:1997;1936-1944.
7. Cudkowicz M.E., McKennar-Yasek D., Sapp P.E., et al. Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis. Ann. Neurol. 41:1997;210-221.
8. Dal Canto M.C., Gurney M.E. Neuropathological changes in two lines of mice carrying a transgene for human mutant Cc. Zn SOD and in mice overexpressing wild-type human SOD A model for familial amyotrophic lateral sclerosis (FALS). Brain Res. 676:1995;25-40.
9. Dal Canto M.C., Gurney M.E. A low expressor line of transgenic mice carrying a mutant human Cu, Zn superoxide dismutase (SOD1) gene develops pathological changes that most closely resemble those in human amyotrophic lateral sclerosis. Acta Neuropathol. 93:1997;537-550.
10. de Belleroche J., Orrell R., King A. Familial amyotrophic lateral sclerosis/motor neurone disease (FALS): a review of current developments. J. Med. Genet. 32:1995;841-847.
11. de Belleroche J., Orrell R.W., Virgo L., et al. Copper, zinc superoxide dismutase (SOD1) and its role in neuronal function and disease with particular relevance to motor neurone disease/amyotrophic lateral sclerosis. Biochem. Soc. Trans. 26:1998;476-480.
12. de Belleroche J., Clifford-Rose F. Zinc, glutamate receptors and motor neurone disease. Lancet. ii:1987;1082-1083.
13. Estevez A.G., Spear N., Manuel S.M., Radi R., Henderson C.E., Barbeito L., Beckman J.S. Nitric oxide and superoxide contribute to motor neuron apoptosis induced by trophic factor deprivation. J. Neurosci. 18:1998;923-931.
14. Estevez A.G., Sampson J.B., Zhuang Y.X., Spear N., Richardson G.J., Crow J.P., Tarpey M.M., Barbeito L., Beckman J.S. Liposome-delivered superoxide dismutase prevents nitric oxide-dependent motor neuron death induced by trophic factor withdrawal. Free Radic. Biol. Med. 28:2000;437-446.
15. Fridovich I. Superoxide radical: an endogenous toxicant. Ann. Rev. Pharmacol. Toxicol. 23:1983;239-257.
16. Ghadge G.D., Lee J.P., Bindokas V.P., Jordan J., Ma L., Miller R.J., Roos R.P. Mutant superoxide dismutase-1-linked familial amyotrophic lateral sclerosis: molecular mechanisms of neuronal death and protection. J. Neurosci. 17:1997;8756-8766.
17. Greenlund L.J.S., Deckworth T.L., Johnson Superoxide dismutase delays neuronal apoptosis E.M. A role for reactive oxygen species in programmed neuronal death. Neuron. 14:1995;303-315.
18. Gurney M.E., Haifeng P., Chiu A., et al. Motor neuron degeneration in mice that express a human Cu/Zn superoxide dismutase mutation. Science. 264:1994;1772-1775.
19. Imaizumi S., Woolworth V., Fishman R.A., Chan P.H. Liposome entrapped superoxide dismutase reduces cerebral infarction in cerebral ischaemia in rats. Stroke. 21:1990;1312-1317.
20. Johnson P.A., et al. Improved cell survival by the reduction of immediate early gene expression in replication-defective mutants of herpes simplex virus 1 but not by a mutation in the viron shut off function. J. Virol. 68:1994;6347-6362.
21. Kostic V., Jackson-Lewis V., de Bilbao F., Dubois-Dauphin M., Przedborski S. Bcl-2: prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis. Science. 277:1997;559-562.
22. Latchman D.S. Molecular biology of herpes simplex latency. Int. J. Exp. Pathol. 71:1990;133-141.
23. Li M., Ona V.O., Guegan C., Chen M., Jackson-Lewis V., Andrews L.J., Olszewski A.J., Stieg P.E., Lee J.P., Przedborski S., Friedlander R.M. Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science. 288:2000;335-339.
24. Liu T.H., Beckmann J.S., Freeman B.A., Hogan E.L., Hsu C.Y. Polyethylene glycol-conjugated superoxide dismutase and catalase reduce ischaemic brain injury. Am. J. Physiol. 256:1989;H589-593.
25. Orrell R.W., Marklund S.L., Hallewell R.A., de Belleroche J. A novel SOD mutant and ALS. Nature. 374:1995;504-505. Correspondence.
26. Orrell R.W., de Belleroche J., Marklund S.L., Bowe F.A., Hallewell R.A. Toxic mutants in Charcot's sclerosis. Nature. 378:1995;343.
27. Orrell R.W., Habgood J.J., Gardiner I., et al. Clinical and functional investigation of 10 missense mutations and a novel frameshift insertion mutation of the gene for copper-zinc superoxide dismutase in UK families with amyotrophic lateral sclerosis. Neurology. 48:1997;746-751.
28. Palmer J., Branston R., Lilley C.E., Robinson M., Groutsi F., Smith J., Latchman D.S., Coffin R.S. Development and optimisation of herpes simplex virus vectors for multiple long term gene delivery to the peripheral nervous system. J. Virol. 74:2000;5604-5618.
29. Pramatarova A., Laganiere J., Roussel J., Brisebois K., Rouleau G.A. Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment. J. Neurosci. 21:2001;3369-3374.
30. Pasinelli P., Houseweart M.K., Brown R.H. Jr., Cleveland D.W. Caspase-1 and -3 are sequentially activated in motor neuron death in Cu/Zn superoxide dismutase-mediated familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA. 97:2000;13901-13906.
31. Rabizadeh S., Gralla E.B., Borchelt D.R., Gwinn R., Valentine J.S., Sisodia S., Wong P., Lee M., Hahn H., Bredesen D.E. Mutations associated with ALS convert superoxide dismutase from a antiapoptotic gene to a proapoptotic gene. Studies in yeast and neural cells. Proc. Natl. Acad. Sci. 92:1995;3024-3028.
32. Reaume A.G., Elliott J.L., Hoffman E.K., Kowall N.W., Ferrante R.J., Siwek D.F., Wilcox H.M., Flood D.G., Beal M.F., Brown R.H. Jr., Scott R.W., Snider W.D. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nature Genet. 13:1996;43-47.
33. Rosen D.R., Siddique T., Patterson D., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 362:1993;59-62.
34. Schapira A.H.V. Oxidative stress in Parkinson's disease. Neuropathol. Exp. Neurobiol. 21:1995;3-9.
35. Smith M.D., Melton L.A., Ensor E.A., Packham G., Anderson P., Kinloch R.A., Latchman D.S. Brn-3a activates the expression of Bcl-XL and promotes neuronal survival in vivo as well as in vitro. Molec. Cell. Neurosci. 17:2001;460-470.
36. Wagstaff M., et al. Protection of neuronal cells from apoptosis by hsp27 delivered with a HSV-based vector. J. Biol. Chem. 274:1999;5061-5069.
37. Yang G., Chan P.H., Chen J., Carlson E., Chen S.F., Weinstein P., Epstein C.J., Camii H. Human copper-zinc superoxide dismutase transgenic mice are highly resistant to reperfusion injury after focal cerebral ischaemia. Stroke. 25:1994;165-170.